- Home
- About
- Collaborative Data Access (SAGs)
- Publications
- For Members
Title | Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry. |
Publication Type | Journal Article |
Year of Publication | 2024 |
Authors | Ray NR, Kunkle BW, Hamilton-Nelson K, Kurup JT, Rajabli F, Qiao M, Vardarajan BN, Cosacak MI, Kizil C, Jean-Francois M, Cuccaro M, Reyes-Dumeyer D, Cantwell L, Kuzma A, Vance JM, Gao S, Hendrie HC, Baiyewu O, Ogunniyi A, Akinyemi RO, Lee W-P, Martin ER, San Wang L-, Beecham GW, Bush WS, Xu W, Jin F, Wang L, Farrer LA, Haines JL, Byrd GS, Schellenberg GD, Mayeux R, Pericak-Vance MA, Reitz C |
Corporate Authors | Alzheimer's Disease Genetics Consortium |
Journal | Alzheimers Dement |
Volume | 20 |
Issue | 8 |
Pagination | 5247-5261 |
Date Published | 08/2024 |
ISSN | 1552-5279 |
Keywords | Aged, Alzheimer Disease, Black People, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Linkage Disequilibrium, Male, Polymorphism, Single Nucleotide |
Abstract | INTRODUCTION: Despite a two-fold risk, individuals of African ancestry have been underrepresented in Alzheimer's disease (AD) genomics efforts. METHODS: Genome-wide association studies (GWAS) of 2,903 AD cases and 6,265 controls of African ancestry. Within-dataset results were meta-analyzed, followed by functional genomics analyses. RESULTS: A novel AD-risk locus was identified in MPDZ on chromosome (chr) 9p23 (rs141610415, MAF = 0.002, p = 3.68×10). Two additional novel common and nine rare loci were identified with suggestive associations (P < 9×10). Comparison of association and linkage disequilibrium (LD) patterns between datasets with higher and lower degrees of African ancestry showed differential association patterns at chr12q23.2 (ASCL1), suggesting that this association is modulated by regional origin of local African ancestry. DISCUSSION: These analyses identified novel AD-associated loci in individuals of African ancestry and suggest that degree of African ancestry modulates some associations. Increased sample sets covering as much African genetic diversity as possible will be critical to identify additional loci and deconvolute local genetic ancestry effects. HIGHLIGHTS: Genetic ancestry significantly impacts risk of Alzheimer's Disease (AD). Although individuals of African ancestry are twice as likely to develop AD, they are vastly underrepresented in AD genomics studies. The Alzheimer's Disease Genetics Consortium has previously identified 16 common and rare genetic loci associated with AD in African American individuals. The current analyses significantly expand this effort by increasing the sample size and extending ancestral diversity by including populations from continental Africa. Single variant meta-analysis identified a novel genome-wide significant AD-risk locus in individuals of African ancestry at the MPDZ gene, and 11 additional novel loci with suggestive genome-wide significance at p < 9×10-7. Comparison of African American datasets with samples of higher degree of African ancestry demonstrated differing patterns of association and linkage disequilibrium at one of these loci, suggesting that degree and/or geographic origin of African ancestry modulates the effect at this locus. These findings illustrate the importance of increasing number and ancestral diversity of African ancestry samples in AD genomics studies to fully disentangle the genetic architecture underlying AD, and yield more effective ancestry-informed genetic screening tools and therapeutic interventions. |
DOI | 10.1002/alz.13880 |
Alternate Journal | Alzheimers Dement |
PubMed ID | 38958117 |
PubMed Central ID | PMC11350055 |
Grant List | P30 AG013854 / AG / NIA NIH HHS / United States / / International Parkinson Fonds / P50 MH060451 / MH / NIMH NIH HHS / United States P30 AG066444 / AG / NIA NIH HHS / United States R01 AG28786-01A1 / / North Carolina A&T University / U01AG46161 / AG / NIA NIH HHS / United States AG05128 / / Duke University / / MRC_ / Medical Research Council / United Kingdom U01AG057659 / GF / NIH HHS / United States R01 AG022374 / AG / NIA NIH HHS / United States U19 AG074865 / AG / NIA NIH HHS / United States P50 AG023501 / AG / NIA NIH HHS / United States U01 AG046152 / AG / NIA NIH HHS / United States P30 AG010124 / AG / NIA NIH HHS / United States U01 HG006375 / HG / NHGRI NIH HHS / United States / / Biogen / U01 AG058654 / AG / NIA NIH HHS / United States NIMH MH60451 / NS / NINDS NIH HHS / United States U54 AG052427 / AG / NIA NIH HHS / United States UO1 HG004610 / / Group Health Research Institute / RC2 AG036528 / AG / NIA NIH HHS / United States P30 AG028377 / AG / NIA NIH HHS / United States R01AG048927 / GF / NIH HHS / United States UO1 HG006375 / / Group Health Research Institute / R01 AG22018 / / Rush University / U01AG46152 / AG / NIA NIH HHS / United States P50 AG008671 / AG / NIA NIH HHS / United States P30 AG10133 / / Indiana University / P50 AG005142 / AG / NIA NIH HHS / United States U01 AG10483 / / Boston University / / / Higher Education Funding Council for England / R01 AG035137 / AG / NIA NIH HHS / United States R01 AG009029 / AG / NIA NIH HHS / United States P50 AG005131 / AG / NIA NIH HHS / United States P50 AG005128 / AG / NIA NIH HHS / United States P30 AG010133 / AG / NIA NIH HHS / United States U24 AG021886 / AG / NIA NIH HHS / United States R01 AG031581 / AG / NIA NIH HHS / United States 5R01AG012101 / / New York University / R01 AG009956 / AG / NIA NIH HHS / United States P50 AG016574 / AG / NIA NIH HHS / United States P50 AG005146 / AG / NIA NIH HHS / United States U01AG058654 / GF / NIH HHS / United States AG025688 / / Emory University / P30AG10161 / AG / NIA NIH HHS / United States / / Alzheimer's Drug Discovery Foundation / U01 AG061356 / AG / NIA NIH HHS / United States RC2 AG036650 / AG / NIA NIH HHS / United States / / Servier / / / Janssen Alzheimer Immunotherapy Research & Development, LLC. / U01 AG032984 / AG / NIA NIH HHS / United States U01 HG008657 / HG / NHGRI NIH HHS / United States / / Brain Net Europe / R01 AG019085 / AG / NIA NIH HHS / United States / / Lumosity / R01 AG013616 / AG / NIA NIH HHS / United States U01 AG024904 / AG / NIA NIH HHS / United States / / Translational Genomics Research Institute / P50 AG008702 / AG / NIA NIH HHS / United States / / Bristol-Myers Squibb Company / R01 AG030146 / AG / NIA NIH HHS / United States R01AG041797 / / NIA FBS (Columbia University) / U01 AG072579 / AG / NIA NIH HHS / United States / / Piramal Imaging / / / DeNDRoN / UL1 RR029893 / RR / NCRR NIH HHS / United States / / Takeda Pharmaceutical Company / 1R01AG035137 / / New York University / R01 AG15819 / / Rush University / R01AG30146 / AG / NIA NIH HHS / United States R01AG15819 / AG / NIA NIH HHS / United States P50 NS039764 / NS / NINDS NIH HHS / United States P01 AG003991 / AG / NIA NIH HHS / United States / / Office of Research and Development / / / Genentech, Inc. / U01 AG016976 / AG / NIA NIH HHS / United States / / US Department of Veterans Affairs Administration / P30 AG008051 / AG / NIA NIH HHS / United States P50 AG005681 / AG / NIA NIH HHS / United States P30 AG013846 / AG / NIA NIH HHS / United States U24 AG056270 / AG / NIA NIH HHS / United States RC2 AG036502 / AG / NIA NIH HHS / United States P01 AG026276 / AG / NIA NIH HHS / United States R01 AG017917 / AG / NIA NIH HHS / United States / / Araclon Biotech / U01 AG057659 / AG / NIA NIH HHS / United States R01 MH080295 / MH / NIMH NIH HHS / United States / / Hersenstichting Nederland Breinbrekend Werk / R01 AG026390 / AG / NIA NIH HHS / United States R01 AG028786 / AG / NIA NIH HHS / United States KL2 RR024151 / RR / NCRR NIH HHS / United States / / Internationale Stiching Alzheimer Onderzoek / P30AG066462 / GF / NIH HHS / United States U24 AG026390 / / NIA FBS (Columbia University) / / / Novartis Pharmaceuticals Corporation / P50 AG005136 / AG / NIA NIH HHS / United States / / Meso Scale Diagnostics, LLC. / / / CereSpir, Inc. / P30 AG012300 / AG / NIA NIH HHS / United States P01 AG03991 / / University of Washington / RF1AG059018 / GF / NIH HHS / United States / / Canadian Institute of Health Research / RF1 AG059018 / AG / NIA NIH HHS / United States / / BioClinica, Inc. / U01 AG062943 / AG / NIA NIH HHS / United States R01 AG012101 / AG / NIA NIH HHS / United States / / GE Healthcare / P50 AG016573 / AG / NIA NIH HHS / United States U24 AG21886 / / National Cell Repository for Alzheimer's Disease (NCRAD) / P50 AG016570 / AG / NIA NIH HHS / United States P50 AG005134 / AG / NIA NIH HHS / United States P30 AG066462 / AG / NIA NIH HHS / United States / / Stichting MS Research / P30 AG008017 / AG / NIA NIH HHS / United States R01AG33193 / / Boston University / / HHMI / Howard Hughes Medical Institute / United States R01 AG042437 / AG / NIA NIH HHS / United States U24 AG041689 / AG / NIA NIH HHS / United States P01 AG019724 / AG / NIA NIH HHS / United States R01AG36042 / AG / NIA NIH HHS / United States RC2AG036547 / AG / NIA NIH HHS / United States R01 AG036042 / AG / NIA NIH HHS / United States P30 AG010161 / AG / NIA NIH HHS / United States AG019757 / / University of Miami / / / Kronos Science / P30 AG08051 / / New York University / IIRG-05-14147 / ALZ / Alzheimer's Association / United States AG010491 / / University of Miami / R01 AG033193 / AG / NIA NIH HHS / United States P50 AG025688 / AG / NIA NIH HHS / United States IIRG-08-89720 / ALZ / Alzheimer's Association / United States / / AbbVie / R37 AG015473 / AG / NIA NIH HHS / United States U24 AG026395 / AG / NIA NIH HHS / United States R01 AG032990 / AG / NIA NIH HHS / United States / / North Bristol NHS Trust Research and Innovation Department / AG021547 / / University of Miami / R01 AG01101 / / Rush University / / / Transition Therapeutics / R01 AG072547 / AG / NIA NIH HHS / United States AG027944 / / University of Miami / AG041232 / AG / NIA NIH HHS / United States A2111048 / / BrightFocus Foundation / U01 AG052410 / AG / NIA NIH HHS / United States / / Johnson & Johnson Pharmaceutical Research & Development LLC. / R01 CA129769 / CA / NCI NIH HHS / United States P50 AG005133 / AG / NIA NIH HHS / United States U01 AG010483 / AG / NIA NIH HHS / United States UO1 AG006781 / / Group Health Research Institute / / / Merck & Co., Inc. / U01AG32984 / AG / NIA NIH HHS / United States U01 AG024904 / GF / NIH HHS / United States RC2 AG036547 / AG / NIA NIH HHS / United States P01 AG002219 / AG / NIA NIH HHS / United States R01 AG17917 / / Rush University / U01 AG006781 / AG / NIA NIH HHS / United States R01 AG041797 / AG / NIA NIH HHS / United States / EB / NIBIB NIH HHS / United States P01 AG010491 / AG / NIA NIH HHS / United States P50 AG005144 / AG / NIA NIH HHS / United States U01AG062943 / GF / NIH HHS / United States R01 AG064614 / AG / NIA NIH HHS / United States / / Glaxo Smith Kline / U01AG072579 / GF / NIH HHS / United States / / Biomedical Laboratory Research Program / U19AG074865 / GF / NIH HHS / United States R01 AG048927 / AG / NIA NIH HHS / United States RF1 AG057473 / AG / NIA NIH HHS / United States R01 AG037212 / AG / NIA NIH HHS / United States R01 AG022018 / AG / NIA NIH HHS / United States U24AG056270 / GF / NIH HHS / United States R01 AG021547 / AG / NIA NIH HHS / United States R01 AG041232 / AG / NIA NIH HHS / United States P50 AG005138 / AG / NIA NIH HHS / United States RF1AG57473 / AG / NIA NIH HHS / United States R01 AG019757 / AG / NIA NIH HHS / United States R01 AG020688 / AG / NIA NIH HHS / United States AG07562 / / University of Pittsburgh / R01AG072547 / GF / NIH HHS / United States / / Alzheimer's Research Trust / / / Pfizer Inc. / / / Illinois Department of Public Health / / / Elan Pharmaceuticals, Inc. / / / NHS trusts / R01 AG030653 / AG / NIA NIH HHS / United States AG052410 / AG / NIA NIH HHS / United States P20 MD000546 / MD / NIMHD NIH HHS / United States R01 AG027944 / AG / NIA NIH HHS / United States / / Eli Lilly and Company / R01 AG017173 / AG / NIA NIH HHS / United States R01 AG025259 / AG / NIA NIH HHS / United States U01 HG004610 / HG / NHGRI NIH HHS / United States U24-AG041689 / / University of Pennsylvania / P30 AG010129 / AG / NIA NIH HHS / United States U01 AG046161 / AG / NIA NIH HHS / United States / WT_ / Wellcome Trust / United Kingdom P30 AG019610 / AG / NIA NIH HHS / United States / / IXICO Ltd. / P50 AG016582 / AG / NIA NIH HHS / United States R01 AG048015 / AG / NIA NIH HHS / United States / / NeuroRx Research / R01AG17917 / AG / NIA NIH HHS / United States U01AG61356 / AG / NIA NIH HHS / United States R01AG36836 / AG / NIA NIH HHS / United States 5R01AG022374 / / New York University / / / EuroImmun; F. Hoffmann-La Roche Ltd / R01 AG041718 / AG / NIA NIH HHS / United States 1RC2AG036502 / / New York University / / / Newcastle University / AG041718 / / University of Pittsburgh / P30 AG028383 / AG / NIA NIH HHS / United States AG05144 / / University of Kentucky / AG030653 / / University of Pittsburgh / R01AG48015 / AG / NIA NIH HHS / United States R01 AG026916 / AG / NIA NIH HHS / United States P50 AG033514 / AG / NIA NIH HHS / United States R01 NS059873 / NS / NINDS NIH HHS / United States # NS39764 / NS / NINDS NIH HHS / United States ADGC / / National Institutes of Health, National Institute on Aging (NIH-NIA) / / / Neurotrack Technologies / / / Fujirebio / / / Lundbeck / MP-V / / BrightFocus Foundation / / / BRACE / R01 AG015819 / AG / NIA NIH HHS / United States R01 AG036836 / AG / NIA NIH HHS / United States / / Eisai Inc. / 5R01AG013616 / / New York University / W81XWH-12-2-0012 / / Department of Defense / R01AG064614 / GF / NIH HHS / United States AG02365 / / University of Pittsburgh / |